Ambient temperature and biomarkers of heart failure: A repeated measures analysis

Environmental Health Perspectives

Volumn 120, Issue 8, 2012, Pages 1083-1087

  Wilker, Elissa H ^a,b   Yeh, Gloria ^a   Wellenius, Gregory A ^c   Davis, Roger B ^a   Phillips, Russell S ^a   Mittleman, Murray A ^a,b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c BROWN UNIVERSITY   (United States)

Author keywords

Biomarkers; Climate variability; Heart failure; Outdoor air; Susceptibility

Indexed keywords

BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; ENDOTHELIN 1; TUMOR NECROSIS FACTOR;

ADULT; AGED; AIR POLLUTION; ARTICLE; CELL DAMAGE; CONTROLLED STUDY; DISEASE SEVERITY; ENVIRONMENTAL TEMPERATURE; FEMALE; HEART FAILURE; HEART MUSCLE CELL; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PUBLIC HEALTH; RANDOMIZED CONTROLLED TRIAL; VULNERABLE POPULATION; WEATHER;

AGED; BIOLOGICAL MARKERS; BOSTON; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; TAI JI; TEMPERATURE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84864773956     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.1104380     Document Type: Article

References (55)

1. Alonso-Martinez JL, Llorente-Diez B, Echegaray-Agara M, Olaz-Preciado F, Urbieta-Echezarreta M, Gonzalez-Arencibia C. 2002. C-reactive protein as a predictor of improvement and readmission in heart failure. Eur J Heart Fail 4(3):331-336.
2. Anand IS, Latini R, Florea VG, Kuskowski MA, Rector T, Masson S, et al. 2005. C-reactive protein in heart failure: Prognostic value and the effect of valsartan. Circulation 112(10):1428-1434.
3. Aronow WS, Ahn C. 2004. Elderly nursing home patients with congestive heart failure after myocardial infarction living in New York City have a higher prevalence of mortality in cold weather and warm weather months. J Gerontol A Biol Sci Med Sci 59(2):146-147.
4. Barclay JL, Miller BG, Dick S, Dennekamp M, Ford I, Hillis GS, et al. 2009. A panel study of air pollution in subjects with heart failure: negative results in treated patients. Occup Environ Med 66(5):325-334.
5. Barnett AG, de Looper M, Fraser JF. 2008. The seasonality in heart failure deaths and total cardiovascular deaths. Aust N Z J Public Health 32(5):408-413.
6. Basu R, Feng WY, Ostro BD. 2008. Characterizing temperature and mortality in nine California counties. Epidemiology 19(1):138-145.
7. Bell ML, O'Neill MS, Ranjit N, Borja-Aburto VH, Cifuentes LA, Gouveia NC. 2008. Vulnerability to heat-related mortality in Latin America: a case-crossover study in São Paulo, Brazil, Santiago, Chile, and Mexico City, Mexico. Int J Epidemiol 37(4):796-804.
8. Berger R, Huelsman M, Strecker K, Bojic A, Moser P, Stanek B et al. 2002. B-type natriuretic peptide predicts sudden death in patients with chronic heart failure. Circulation 105(20):2392-2397.
9. Bolger AP, Sharma R, Li W, Leenarts M, Kalra PR, Kemp M et al. 2002. Neurohormonal activation and the chronic heart failure syndrome in adults with congenital heart disease. Circulation 106(1):92-99.
10. Boulay F, Berthier F, Sisteron O, Gendreike Y, Gibelin P. 1999. Seasonal variation in chronic heart failure hospitalizations and mortality in France. Circulation 100(3):280-286.
11. Braunwald E. 2008. Biomarkers in heart failure. N Engl J Med 358(20):2148-2159.
12. Cheng V, Kazanagra R, Garcia A, Lenert L, Krishnaswamy P, Gardetto N, et al. 2001. A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study. J Am Coll Cardiol 37(2):386-391.
13. Criteria Committee of the New York Heart Association, ed. 1994. Nomenclature and Criteria for Diagnosis of Diseases of the Heart and Great Vessels. 9th Edition. Boston, MA: Little Brown & Co., 253-256.
14. Cui J, Arbab-Zadeh A, Prasad A, Durand S, Levine BD, Crandall CG. 2005. Effects of heat stress on thermoregulatory responses in congestive heart failure patients. Circulation 112(15):2286-2292.
15. Curriero FC, Heiner KS, Samet JM, Zeger SL, Strug L, Patz JA. 2002. Temperature and mortality in 11 cities of the eastern United States. Am J Epidemiol 155(1):80-87.
16. Damgaard M, Goetze JP, Norsk P, Gadsboll N. 2007. Altered sodium intake affects plasma concentrations of BNP but not proBNP in healthy individuals and patients with compensated heart failure. Eur Heart J 28(22):2726-2731.
17. Delfino RJ, Staimer N, Tjoa T, Polidori A, Arhami M, Gillen DL et al. 2008. Circulating biomarkers of inflammation, antioxidant activity, and platelet activation are associated with primary combustion aerosols in subjects with coronary artery disease. Environ Health Perspect 116:898-906.
18. Dubowsky SD, Suh H, Schwartz J, Coull BA, Gold DR. 2006. Diabetes, obesity, and hypertension may enhance associations between air pollution and markers of systemic inflammation. Environ Health Perspect 114:992-998.
19. Dunlay SM, Weston SA, Redfield MM, Killian JM, Roger VL. 2008. Tumor necrosis factor-a and mortality in heart failure: A community study. Circulation 118(6):625-631.
20. Folstein MF, Folstein SE, McHugh PR. 1975. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12(3):189-198.
21. Fonarow GC. 2008. Epidemiology and risk stratification in acute heart failure. Am Heart J 155(2):200-207.
22. Gold DR, Litonjua A, Schwartz J, Lovett E, Larson A, Nearing B et al. 2000. Ambient pollution and heart rate variability. Circulation 101(11):1267-1273.
23. Goldberg MS, Giannetti N, Burnett RT, Mayo NE, Valois MF, Brophy JM. 2008. A panel study in congestive heart failure to estimate the short-term effects from personal factors and environmental conditions on oxygen saturation and pulse rate. Occup Environ Med 65(10):659-666.
24. Goldberg MS, Giannetti N, Burnett RT, Mayo NE, Valois MF, Brophy JM. 2009. Shortness of breath at night and health status in congestive heart failure: effects of environmental conditions and health-related and dietary factors. Environ Res 109(2):166-174.
25. Gotsman I, Zwas D, Admon D, Lotan C, Keren A. 2010. Seasonal variation in hospital admission in patients with heart failure and its effect on prognosis. Cardiology 117(4):268-274.
26. Halonen JI, Zanobetti A, Sparrow D, Vokonas PS, Schwartz J. 2010. Associations between outdoor temperature and markers of inflammation: a cohort study. Environ Health 9:42; doi:10.1186/1476-069X-9-42 [Online 23 July 2010].
27. Hampel R, Breitner S, Rückerl R, Frampton MW, Koenig W, Phipps RP, et al. 2010. Air temperature and inflammatory and coagulation responses in men with coronary or pulmonary disease during the winter season. Occup Environ Med 67(6):408-416.
28. Hausman JA. 1978. Specification tests in econometrics. Econometrica 46(6):1251-1271.
29. Hausman JA, Taylor W. 1981. Panel data and unobservable individual effects. Econometrica 49(6):1377-1398.
30. Koglin J, Pehlivanli S, Schwaiblmair M, Vogeser M, Cremer P, vonScheidt W. 2001. Role of brain natriuretic peptide in risk stratification of patients with congestive heart failure. J Am Coll Cardiol 38(7):1934-1941.
31. Koken PJ, Piver WT, Ye F, Elixhauser A, Olsen LM, Portier CJ. 2003. Temperature, air pollution, and hospitalization for cardiovascular diseases among elderly people in Denver. Environ Health Perspect 111:1312-1317.
32. Latini R, Masson S, de Angelis N, Anand I. 2002. Role of brain natriuretic peptide in the diagnosis and management of heart failure: Current concepts. J Card Fail 8(5):288-299.
33. Levin ER. 1995. Endothelins. N Engl J Med 333(6):356-363.
34. Levine B, Kalman J, Mayer L, Fillit HM, Packer M. 1990. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 323(4):236-241.
35. Logeart D, Thabut G, Jourdain P, Chavelas C, Beyne P, Beauvais F et al. 2004. Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure. J Am Coll Cardiol 43(4):635-641.
36. Martinez-Selles M, Garcia Robles JA, Munoz R, Serrano JA, Frades E, Dominguez Munoa M, et al. 2004. Pharmacological treatment in patients with heart failure: patients knowledge and occurrence of polypharmacy, alternative medicine and immunizations. Eur J Heart Fail 6(2):219-226.
37. National Climatic Data Center. 2011. Climate Data Online. Available: http://www.ncdc.noaa.gov/cdo-web/ [accessed 2 July 2012].
38. Oka RK, Stotts NA, Dae MW, Haskell WL, Gortner SR. 1993. Daily physical activity levels in congestive heart failure. Am J Cardiol 71(11):921-925.
39. O'Neill MS, Veves A, Sarnat JA, Zanobetti A, Gold DR, Economides PA, et al. 2007. Air pollution and inflammation in type 2 diabetes: a mechanism for susceptibility. Occup Environ Med 64(6):373-379.
40. O'Neill MS, Zanobetti A, Schwartz J. 2005. Disparities by race in heat-related mortality in four U.S. cities: the role of air conditioning prevalence. J Urban Health 82(2):191-197.
41. Ostro B, Rauch S, Green R, Malig B, Basu R. 2010. The effects of temperature and use of air conditioning on hospitalizations. Am J Epidemiol 172(9):1053-1061.
42. Rückerl R, Ibald-Mulli A, Koenig W, Schneider A, Woelke G, Cyrys J, et al. 2006. Air pollution and markers of inflammation and coagulation in patients with coronary heart disease. Am J Respir Crit Care Med 173(4):432-441.
43. Sato Y, Takatsu Y, Kataoka K, Yamada T, Taniguchi R, Sasayama S, et al. 1999. Serial circulating concentrations of C-reactive protein, interleukin (IL)-4, and IL-6 in patients with acute left heart decompensation. Clin Cardiol 22(12):811-813.
44. Schneider A, Panagiotakos D, Picciotto S, Katsouyanni K, Lowel H, Jacquemin B, et al. 2008. Air temperature and inflammatory responses in myocardial infarction survivors. Epidemiology 19(3):391-400.
45. Sharma R, Coats AJ, Anker SD. 2000. The role of inflammatory mediators in chronic heart failure: cytokines, nitric oxide, and endothelin-1. Int J Cardiol 72(2):175-186.
46. Steadman RG. 1984. A universal scale of apparent temperature. J Climate Appl Meteorol 23:1674-1687.
47. Stewart S, McIntyre K, Capewell S, McMurray JJ. 2002. Heart failure in a cold climate. seasonal variation in heart failure-related morbidity and mortality. J Am Coll Cardiol 39(5):760-766.
48. Teerlink JR. 2005. Endothelins: pathophysiology and treatment implications in chronic heart failure. Curr Heart Fail Rep 2(4):191-197.
49. van den Berg-Emons H, Bussmann J, Balk A, Keijzer-Oster D, Stam H. 2001. Level of activities associated with mobility during everyday life in patients with chronic congestive heart failure as measured with an "activity monitor". Phys Ther 81(9):1502-1511.
50. Wei CM, Lerman A, Rodeheffer RJ, McGregor CG, Brandt RR, Wright S et al. 1994. Endothelin in human congestive heart failure. Circulation 89(4):1580-1586.
51. Wellenius GA, Yeh GY, Coull BA, Suh HH, Phillips RS, Mittleman MA. 2007. Effects of ambient air pollution on functional status in patients with chronic congestive heart failure: a repeated-measures study. Environ Health 6:26; doi:10.1186/1476-069X-6-26 [Online 10 September 2007].
52. Wilker EH, Alexeeff SE, Suh H, Vokonas PS, Baccarelli A, Schwartz J. 2011. Ambient pollutants, polymorphisms associated with microRNA processing and adhesion molecules: the Normative Aging Study. Environ Health 10:45; doi:10.1186/1476-069X-10-45 [Online 21 May 2011].
53. Yang LL, Arab S, Liu P, Stewart DJ, Husain M. 2005. The role of endothelin-1 in myocarditis and inflammatory cardiomyopathy: old lessons and new insights. Can J Physiol Pharmacol 83(1):47-62.
54. Yeh GY, McCarthy EP, Wayne PM, Stevenson LW, Wood MJ, Forman D, et al. 2011. Tai chi exercise in patients with chronic heart failure: a randomized clinical trial. Arch Intern Med 171(8):750-757.
55. Zanobetti A, Schwartz J. 2008. Temperature and mortality in nine U.S. cities. Epidemiology 19(4):563-570.